Mode
Text Size
Log in / Sign up

Complete mesocolic excision with central vascular ligation improves survival in colon cancer patientsCould a more thorough colon cancer surgery help patients live longer?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider CME with CVL for colon cancer surgery given survival benefits in meta-analysis, though precise significance remains debated.

This systematic review and meta-analysis compared complete mesocolic excision with central vascular ligation (CME+CVL) to surgery without this concept in 4,575 colon cancer patients from 11 prospective trials (6 randomized controlled trials and 5 prospective clinical trials). The analysis included 2,244 patients in the CME+CVL group and 2,331 in the non-CME+CVL group, though specific study settings were not reported.

The primary finding was significantly improved disease-free survival and overall survival in the CME+CVL group, though exact hazard ratios, absolute numbers, and confidence intervals were not reported. Postoperative outcomes including intraoperative and postoperative morbidity and mortality showed no significant differences between the two groups. Other secondary outcomes such as operative time, intraoperative blood loss, conversion rate to open surgery, and length of postoperative hospital stay were analyzed but specific results were not detailed.

Key limitations include the absence of reported effect sizes, absolute numbers, and confidence intervals for the survival outcomes. The precise significance of CME and CVL in improving outcomes remains a subject of ongoing debate according to the authors. While pooled analyses demonstrated significantly improved DFS and OS with no significant heterogeneity across studies, clinicians should interpret these findings as showing association rather than definitive causation. The practice relevance suggests CME with CVL may represent an optimal surgical strategy for colon cancer management, but individual patient factors and surgeon expertise should guide surgical approach decisions.

When facing colon cancer surgery, patients and surgeons want the same thing: the best chance of a cure with the fewest complications. A new analysis of 11 studies, involving over 4,500 patients, compared two surgical approaches. It found that a more thorough technique—which removes more of the tissue and blood vessels around the tumor—was linked to better long-term survival and a lower chance of the cancer coming back, compared to standard surgery.

The key finding is that this more extensive surgery, called complete mesocolic excision with central vascular ligation, did not appear to make the operation itself riskier in the short term. Rates of complications, hospital stays, and other postoperative problems were similar between the two groups. This suggests surgeons might be able to aim for a more complete removal of cancer without trading off immediate safety.

It's important to understand what this analysis can and cannot tell us. The data comes from combining results of existing studies, not from a single new trial. While the pooled results are promising, the review itself notes that the precise role and benefit of this surgical technique is still debated among experts. The analysis shows an association, but more research is needed to fully define its place in treatment.

What this means for you:
A more thorough colon cancer surgery was linked to better survival without more short-term risks.

Study Details

Study typeMeta analysis
Sample sizen = 4,575
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: The concept of complete mesocolic excision (CME) with central vascular ligation (CVL) has been introduced as a surgical technique for colon cancer. Nonetheless, the precise significance of CME and CVL in improving outcomes remains a subject of ongoing debate. The objective of this systematic review and meta-analysis of prospective trials is to compare postoperative and oncological outcomes between CME with CVL and surgery without the concept of CME + CVL in patients with colon cancer. MATERIALS AND METHODS: A systematic literature search and meta-analyses were performed to evaluate both postoperative and oncological outcomes. Postoperative outcomes included operative time, intraoperative blood loss, conversion rate to open surgery, intraoperative and postoperative morbidity and mortality, and length of postoperative hospital stay. Oncological outcomes included disease-free survival (DFS), overall survival (OS), and the cumulative incidence of recurrence and death. RESULTS: A total of 11 studies met the inclusion criteria, including six randomized controlled trials and five prospective clinical trials, comprising a total of 4575 patients (2244 in the CME + CVL group and 2331 in the non-CME + CVL group). Pooled analyses demonstrated significantly improved DFS and OS in the CME + CVL group, with no significant heterogeneity across studies. Additionally, there were no significant differences between the two groups in terms of postoperative outcomes, including morbidity and mortality. CONCLUSIONS: This systematic review and meta-analysis demonstrated that CME with CVL significantly improves long-term oncological outcomes in patients with colon cancer, without compromising short-term postoperative outcomes. CME with CVL may represent an optimal surgical strategy for the management of colon cancer.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.